Follow
Fengzhi Li
Fengzhi Li
Chief Scientist and Associate professor of Oncology, Roswell Park Cancer Institute
Verified email at roswellpark.org - Homepage
Title
Cited by
Cited by
Year
Control of apoptosis and mitotic spindle checkpoint by survivin
F Li, G Ambrosini, EY Chu, J Plescia, S Tognin, PC Marchisio, DC Altieri
Nature 396 (6711), 580-584, 1998
29721998
Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway
A Papapetropoulos, D Fulton, K Mahboubi, RG Kalb, DS O'Connor, F Li, ...
Journal of Biological Chemistry 275 (13), 9102-9105, 2000
9782000
Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin
DS O'Connor, D Grossman, J Plescia, F Li, H Zhang, A Villa, S Tognin, ...
Proceedings of the National Academy of Sciences 97 (24), 13103-13107, 2000
9342000
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
F Li, EJ Ackermann, CF Bennett, AL Rothermel, J Plescia, S Tognin, ...
Nature cell biology 1 (8), 461-466, 1999
8631999
Control of apoptosis during angiogenesis by survivin expression in endothelial cells
DS O'Connor, JS Schechner, C Adida, M Mesri, AL Rothermel, F Li, ...
The American journal of pathology 156 (2), 393-398, 2000
7822000
Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma
D Grossman, JM McNiff, F Li, DC Altieri
Journal of Investigative Dermatology 113 (6), 1076-1081, 1999
5521999
Survivin study: what is the next wave?
F Li
Journal of cellular physiology 197 (1), 8-29, 2003
4702003
Transcriptional analysis of human survivin gene expression
F LI, DC ALTIERI
Biochemical Journal 344 (2), 305-311, 1999
4421999
Role of survivin and its splice variants in tumorigenesis
F Li
British journal of cancer 92 (2), 212-216, 2005
3782005
Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line.
D Grossman, JM Mcniff, F Li, DC Altieri
Laboratory investigation; a journal of technical methods and pathology 79 (9 …, 1999
3451999
Nuclear or cytoplasmic expression of survivin: what is the significance?
F Li, J Yang, N Ramnath, MM Javle, D Tan
International journal of cancer 114 (4), 509-512, 2005
3372005
The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression
F Li, DC Altieri
Cancer research 59 (13), 3143-3151, 1999
3211999
Survivin Study: An update of “What is the next wave?”
F Li, X Ling
Journal of cellular physiology 208 (3), 476-486, 2006
3162006
Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for …
F Li, T Jiang, Q Li, X Ling
American journal of cancer research 7 (12), 2350, 2017
2382017
Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest
X Ling, RJ Bernacki, MG Brattain, F Li
Journal of Biological Chemistry 279 (15), 15196-15203, 2004
2362004
Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin
SW Muchmore, J Chen, C Jakob, D Zakula, ED Matayoshi, W Wu, ...
Molecular cell 6 (1), 173-182, 2000
2222000
DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells
M Zhou, L Gu, F Li, Y Zhu, WG Woods, HW Findley
Journal of Pharmacology and Experimental Therapeutics 303 (1), 124-131, 2002
2192002
Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal
J Ruef, GN Rao, F Li, C Bode, C Patterson, A Bhatnagar, MS Runge
Circulation 97 (11), 1071-1078, 1998
2061998
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
F Li, I Aljahdali, X Ling
Journal of Experimental & Clinical Cancer Research 38 (1), 368, 2019
1942019
Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture
P Apontes, OV Leontieva, ZN Demidenko, F Li, MV Blagosklonny
Oncotarget 2 (3), 222, 2011
1862011
The system can't perform the operation now. Try again later.
Articles 1–20